FDA Panel Unanimously Votes Down Parkinson’s Drug

In CategoryDrugs and Drug Companies
ByRuss Bianchi

A federal health panel unanimously voted Monday that a drug for Parkinson’s disease from Teva Pharmaceuticals has not been shown to slow progress of the debilitating neurological disease.

FDA Panel Unanimously Votes Down Parkinson’s Drug

Share

Tags: , ,

Comments are closed.